Bausch Health Companies (BHC) Net Income towards Common Stockholders (2009 - 2026)

Bausch Health Companies has reported Net Income towards Common Stockholders for 18 years, with the latest figure at $260.0 million in Q2 2026.

• Quarterly Net Income towards Common Stockholders rose 103.12% year-over-year to $260.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$1.1 billion (down 2377.08% YoY) and the FY2025 annual result came in at $120.0 million, up 266.67% from the prior year.
• Net Income towards Common Stockholders grew to $260.0 million in Q2 2026 per BHC's latest filing, from -$1.4 billion in the prior quarter.
• Over five years, Net Income towards Common Stockholders peaked at $403.0 million in Q3 2022 and troughed at -$1.4 billion in Q1 2026.
• A 5-year average of -$108.1 million and a median of -$71.5 million in 2022 frame the typical range for Net Income towards Common Stockholders.
• The sharpest annual moves came in 2025 and 2026: Net Income towards Common Stockholders surged 12900.0% in 2025, then slumped 1563.95% in 2026.
• Over 5 years, Net Income towards Common Stockholders stood at -$410.0 million in 2022, then surged by 88.54% to -$47.0 million in 2023, then soared by 308.51% to $98.0 million in 2024, then sank by 205.1% to -$103.0 million in 2025, then surged by 352.43% to $260.0 million in 2026.
• According to Business Quant data, Net Income towards Common Stockholders over the past three periods registered $260.0 million, -$1.4 billion, and -$103.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.